|
1
|
Wu M, Zhao JK, Hu XS, Wang PH, Qin Y, Lu
YC, Yang J, Liu AM, Wu DL, Zhang ZF, et al: Association of smoking,
alcohol drinking and dietary factors with esophageal cancer in
high- and low-risk areas of jiangsu province, china. World J
Gastroenterol. 12:1686–1693. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tachimori Y, Ozawa S, Numasaki H,
Fujishiro M, Matsubara H, Oyama T, Shinoda M, Toh Y, Udagawa H, Uno
T, et al: Registration committee for esophageal cancer of the Japan
esophageal society. Comprehensive registry of esophageal cancer in
Japan, 2009. Esophagus. 13:110–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ando N, Kato H, Igaki H, Shinoda M, Ozawa
S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeMeester SR: Adenocarcinoma of the
esophagus and cardia: A review of the disease and its treatment.
Ann Surg Oncol. 13:12–30. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sjoquist KM, Burmeister BH, Smithers BM,
Zalcberg JR, Simes RJ, Barbour A and Gebski V; Australasian
Gastro-Intestinal Trials Group, : Survival after neoadjuvant
chemotherapy or chemoradiotherapy for resectable oesophageal
carcinoma: An updated meta-analysis. Lancet Oncol. 12:681–692.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Hagen P, Hulshof MC, van Lanschot JJ,
Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al: Preoperative
chemoradiotherapy for esophageal or junctional cancer. N Engl J
Med. 366:2074–2084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siewert JR and Stein HJ: Classification of
adenocarcinoma of the oesophagogastric junction. Br J Surg.
85:1457–1459. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sasako M, Sano T, Yamamoto S, Sairenji M,
Arai K, Kinoshita T, Nashimoto A and Hiratsuka M; Japan Clinical
Oncology Group (JCOG9502), : Left thoracoabdominal approach versus
abdominal-transhiatal approach for gastric cancer of the cardia or
subcarsia: A randomized controlled trial. Lancet Oncol. 7:644–651.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clavien PA, Barkun J, de Oliveira ML,
Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J,
Slankamenac K, Bassi C, et al: The Clavien-Dindo classification of
surgical complications: Five-year experience. Ann Surg.
250:187–196. 2000. View Article : Google Scholar
|
|
10
|
Curtis NJ, Noble F, Bailey IS, Kelly JJ,
Byrne JP and Underwood TJ: The relevance of the Siewert
classification in the era of multimodal therapy for adenocarcinoma
of the gastro-oesophageal junction. J Surg Oncol. 109:202–207.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gertler R, Stein HJ, Langer R, Nettelmann
M, Schuster T, Hoefler H, Siewert JR and Feith M: Long-term outcome
of 2920 patients with cancers of the esophagus and esophagogastric
junction: Evaluation of the new union internationale contre le
cancer/american joint cancer committee staging system. Ann Surg.
253:689–698. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hosokawa Y and Kinoshita T, Konishi M,
Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K,
Sugiyama Y and Kinoshita T: Clinicopathological features and
prognostic factors of adenocarcinoma of the esophagogastric
junction according to Siewert classification: Experiences at a
single institution in Japan. Ann Surg Oncol. 19:677–683. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sjoquist KM, Burmeister BH, Smithers BM,
Zalcberg JR, Simes RJ, Barbour A and Gebski V; Australasian
Gastro-Intestinal Trials Group, : Survival after neoadjuvant
chemotherapy or chemoradiotherapy for resectable oesophageal
carcinoma: An updated meta-analysis. Lancet Oncol. 12:681–692.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kitagawa H, Namikawa T, Munekage M,
Fujisawa K, Munekgae E, Kobayashi M and Hanazaki K: Outcomes of
thoracoscopic esophagectomy in prone position with laparoscopic
gastric mobilization for esophageal cancer. Langenbecks Arch Surg.
401:699–705. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Booka E, Takeuchi H, Nishi T, Matsuda S,
Kaburagi T, Fukuda K, Nakamura R, Takahashi T, Wada N, Kawakubo H,
et al: The impact of postoperative complications on survivals after
esophagectomy for esophageal cancer. Medicine (Baltimore).
94:e13692015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kataoka K, Takeuchi H, Mizusawa J, Igaki
H, Ozawa S, Abe T, Nakamura K, Kato K, Ando N and Kitagawa Y:
Prognostic impact of postoperative morbidity after esophagectomy
for esophageal cancer: Exploratory analysis of JCOG9907. Ann Surg.
265:1152–1157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Markar S, Gronnier C, Duhamel A, Mabrut
JY, Bail JP, Carrere N, Lefevre JH, Brigand C, Vaillant JC, Adham
M, et al: The impact of severe anastomotic leakage on long-term
survival and cancer recurrence after surgical resection for
esophageal malignancy. Ann Surg. 262:972–980. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okamura A, Takeuchi H, Matsuda S, Ogura M,
Miyasho T, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y
and Kitagawa Y: Factors affecting cytokine change after
esophagectomy for esophageal cancer. Ann Surg Oncol. 22:3130–3135.
2015. View Article : Google Scholar : PubMed/NCBI
|
